De novo design of antiviral and antibacterial peptides with varying loop structures

Journal of AIDS and Clinical Research

Volumn 3, Issue SPL ISSUE2, 2012, Pages

  Wang, Guangshun ^a   Buckheit, Karen W ^b   Mishra, Biswajit ^a   Lushnikova, Tamara ^a   Buckheit Jr , Robert W ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ImQuest Biosciences   (United States)

Author keywords

Antimicrobial peptides; HIV 1; Microbicides; Peptide stability

Indexed keywords

EID: 84879811817     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.S2-003     Document Type: Article

References (27)

1. Buckheit RW (2001) Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection. Expert Opin Investig Drugs 10: 1423-1442.
2. Turpin JA (2002) Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs 11: 1077-1097.
3. Boman HG (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254: 197-215.
4. Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491-511.
5. Lehrer RI (2007) Multispecific myeloid defensins. Curr Opin Hematol 14: 16-21.
6. Zasloff M (2002) Antimicrobial peptides of multicellullar organisms. Nature 415: 359-365.
7. Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, et al. (2004) Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides. Virology 323: 268-275.
8. VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, et al. (2005) Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. J Virol 79: 11598-11606.
9. Wachinger M, Klenschmidt A, Winder D, von Pechmann N, Ludvigsen A, et al. (1998) Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol 79: 731-740
10. Robinson WE, McDougall B, Tran D, Selsted ME (1998) Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leuko Biol 63: 94-100.
11. Penberthy WT, Chari S, Cole AL, Cole AM (2011) Retrocyclins and their activity against HIV-1. Cell Mol Life Sci 68: 2231-2242.
12. Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Soderlund L (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5: 410-415.
13. Wang G, Watson KM, Buckheit RW Jr (2008) Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob Agents Chemother 52: 3438-3440.
14. Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ (2008) Cyclotides as natural anti-HIV agents. Biopolymers 90: 51-60.
15. Wong JH, Legowska A, Rolka K, Ng TB, Hui M, et al. (2011) Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides 32: 1117-1122.
16. Beard JA, Bearden A, Striker R (2011) Vitamin D and the anti-viral state. J Clin Virol 50: 194-200.
17. Wang G, Li X, Wang Z (2009) The updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933-D937.
18. Wang Z, Wang G (2004) APD: the antimicrobial peptide database. Nucleic Acids Res 32: D590-D592.
19. Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr (2010) Identification of novel human immunodeficiency virus type 1 inhibitory peptides based on the antimicrobial peptide database. Antimicrob Agents Chemother 54: 1343-1346.
20. Buckheit RW, Jr., Kinjerski TL, Fliakas-Boltz V, Russell JD, Stup TL, et al. (1995) Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide. Antimicrob Agents Chemother 39: 2718-2727.
21. Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283: 32637-32643.
22. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, et al. (1996) Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271: 28375-28381.
23. Li X, Li Y, Han H, Miller DM, Wang G (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal mem brane-targeting antimicrobial and anticancer region. J Am Chem Soc 128: 5776-5785.
24. Fehlbaum P, Bulet P, Chernysh S, Briand JP, Roussel JP, et al. (1996) Structureactivity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci U S A 93: 1221-1225.
25. Mandard N, Sodano P, Labbe H, Bonmatin JM, Bulet P, et al. (1998) Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur J Biochem 256: 404-410.
26. Wang G (2010) Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies. CABI, England.
27. Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, et al. (2008) Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J N at Prod 71: 47-52.